16.90
price down icon0.88%   -0.15
after-market Handel nachbörslich: 16.75 -0.15 -0.89%
loading
Schlusskurs vom Vortag:
$17.05
Offen:
$16.9
24-Stunden-Volumen:
306.28K
Relative Volume:
0.80
Marktkapitalisierung:
$520.09M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-3.0839
EPS:
-5.48
Netto-Cashflow:
$11.70M
1W Leistung:
-0.35%
1M Leistung:
+9.39%
6M Leistung:
-22.23%
1J Leistung:
-22.12%
1-Tages-Spanne:
Value
$16.57
$17.19
1-Wochen-Bereich:
Value
$16.51
$17.30
52-Wochen-Spanne:
Value
$14.76
$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name
Firmenname
Fulgent Genetics Inc
Name
Telefon
626-350-0537
Name
Adresse
4399 SANTA ANITA AVE, EL MONTE
Name
Mitarbeiter
0
Name
Nächster Verdiensttermin
2024-11-08
Name
Neueste SEC-Einreichungen
Name
FLGT's Discussions on Twitter

Vergleichen Sie FLGT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
FLGT
Fulgent Genetics Inc
16.90 520.09M 290.71M -163.43M 11.70M -5.48
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
497.60 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.00 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
419.95 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.98 33.45B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
176.30 31.62B 15.41B 1.37B 2.11B 7.50

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-12-07 Eingeleitet UBS Neutral
2022-12-08 Herabstufung Piper Sandler Overweight → Neutral
2022-11-18 Eingeleitet Raymond James Outperform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-02-04 Fortgesetzt Piper Sandler Overweight
2021-08-05 Fortgesetzt Credit Suisse Underperform
2021-01-08 Herabstufung Credit Suisse Neutral → Underperform
2020-11-24 Herabstufung BTIG Research Buy → Neutral
2020-08-20 Eingeleitet Oppenheimer Outperform
2020-05-29 Eingeleitet BTIG Research Buy
2019-11-05 Hochstufung Piper Jaffray Neutral → Overweight
2018-03-01 Herabstufung Piper Jaffray Overweight → Neutral
2017-11-07 Herabstufung Raymond James Outperform → Mkt Perform
Alle ansehen

Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten

pulisher
01:18 AM

Where are the Opportunities in (FLGT) - news.stocktradersdaily.com

01:18 AM
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Has $3.88 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Purchases New Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 29, 2025
pulisher
Mar 27, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Intech Investment Management LLC - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Magnetar Financial LLC Buys Shares of 16,977 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 27, 2025
pulisher
Mar 25, 2025

A better buy-in window may exist right now for Fulgent Genetics Inc (FLGT) - SETE News

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Purchases 112,011 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 23, 2025
pulisher
Mar 22, 2025

Fulgent Genetics Inc (FLGT) Shares Up 1.18% on Mar 22 - GuruFocus.com

Mar 22, 2025
pulisher
Mar 22, 2025

Amundi Boosts Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Fulgent Genetics Inc (FLGT) Shares Up 0.12% on Mar 21 - GuruFocus.com

Mar 21, 2025
pulisher
Mar 20, 2025

(FLGT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 20, 2025

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy - Seeking Alpha

Mar 20, 2025
pulisher
Mar 15, 2025

Fulgent Genetics Inc (FLGT) Getting Ready To Launch, Waiting For The Long Term Buyers - Stocks Register

Mar 15, 2025
pulisher
Mar 15, 2025

AlphaQuest LLC Buys 27,085 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 15, 2025
pulisher
Mar 14, 2025

Proficio Capital Partners LLC Acquires Shares of 22,238 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 14, 2025
pulisher
Mar 12, 2025

Fulgent Genetics (NASDAQ:FLGT) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Mar 12, 2025
pulisher
Mar 11, 2025

Proficio Capital Partners LLC Purchases New Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up on Insider Buying Activity - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Update - MarketBeat

Mar 10, 2025
pulisher
Mar 09, 2025

Fulgent Genetics (NASDAQ:FLGT) Upgraded to Hold at StockNews.com - MarketBeat

Mar 09, 2025
pulisher
Mar 08, 2025

Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

Fulgent Genetics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Fulgent Genetics Chief Financial Officer Acquires 40% More Stock - Simply Wall St

Mar 07, 2025
pulisher
Mar 06, 2025

Insider Buying: Fulgent Genetics, Inc. (NASDAQ:FLGT) CFO Buys 100,000 Shares of Stock - MarketBeat

Mar 06, 2025
pulisher
Mar 06, 2025

Fulgent Genetics CFO Paul Kim purchases $1.6 million in company stock By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 05, 2025

Fulgent Genetics CFO Makes a Major Stock Purchase! - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Buying: Paul Kim Acquires 100,000 Shares of Fulgent Gene - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Fulgent Genetics CFO Paul Kim purchases $1.6 million in company stock - Investing.com Australia

Mar 05, 2025

Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$169.20
price up icon 1.12%
$141.41
price down icon 1.76%
diagnostics_research LH
$232.74
price up icon 1.18%
diagnostics_research WAT
$368.57
price up icon 1.77%
diagnostics_research MTD
$1,180.91
price up icon 0.32%
diagnostics_research IQV
$176.30
price down icon 0.61%
Kapitalisierung:     |  Volumen (24h):